Why this Newsletter
Reimbursement summits dedicated exclusively to medical devices and digital health technologies are not held often, so we wanted to make you aware of this summit to be held in October.
The CBI’s MedTech Reimbursement Summit is dedicated exclusively to medical and digital health technologies is taking place October 24 and 25, 2018 at The Magnolia Hotel in downtown Dallas (Texas).
Susan Rowinski, President & CEO of Rowinski Group, is excited to join other industry experts to help lead the Summit’s presentations and discussions on some of the most pressing reimbursement and market access challenges facing medical and digital technology manufacturers today.
Developed by industry, for industry, this program provides an excellent opportunity to connect with highly experienced thought leaders in the medical device and digital health technology fields and to collaborate and benchmark with others through peer-to-peer exchange. To learn more about this program and to see the full lineup of speakers and topics, view the complete brochure online today.
I invite you to take advantage of my exclusive discount for this program. Register with the promo code SUS500 by to save $500 off the standard rate. Don’t miss this opportunity to join in interactive discussions, benefit from critical industry insights and address market access and reimbursement challenges today.
I hope that you can join us at this important event. For any questions, please reach out to me firstname.lastname@example.org
About Rowinski Group
Founded in 2004, Rowinski Group LLC is a reimbursement and healthcare payer data analytics consulting firm for medical device, digital health, diagnostics, and imaging companies. Rowinski Group is based in Silicon Valley – San Francisco bay area with offices at selected client locations.
Rowinski Group has two core service offerings; securing codes and reimbursement on behalf of companies and applying healthcare payer data analytics to help solve companies’ complex business issues such as responding to questions from the FDA and U.S. Payers.
Through these service offerings Rowinski Group helps U.S. and international companies build their U.S. market share for the medical technology they are developing and selling. For more information visit www.rowinskigroup.com